86.1%
Impella 2.5IABPImpellacomplex three-vessel and/or unprotected left main diseaseextensive coronary artery diseaseCAD
…ft ventricular ejection fraction (LVEF) ≤35% were randomised to Impella 2.5 versus IABP. The trial was terminated early for futility. The 3…